(Q64927703)

1 July 2019

title

Prognostic markers for colorectal cancer: expression of P53 and BCL2. (English)

1 reference

1 July 2019

1 reference

1 reference

H Pereira

1

1 reference

1 July 2019

S Silva

2

1 reference

1 July 2019

R Julião

3

1 reference

1 July 2019

P Garcia

4

1 reference

1 July 2019

F Perpétua

5

1 reference

1 July 2019

publication date

1 February 1997

1 reference

1 July 2019

published in

World Journal of Surgery

1 reference

1 July 2019

volume

21

1 reference

1 July 2019

page(s)

210-213

1 reference

1 July 2019

issue

2

1 reference

1 July 2019

https://scigraph.springernature.com/pub.10.1007/s002689900218

exact match

0 references

cites work

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Advances in the genetics and molecular biology of colorectal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Multifactorial analysis of p53 alteration in human cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

p53 immunohistochemistry: a word of caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

P53 in tumour pathology: can we trust immunocytochemistry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Relationship among p53, stage, and prognosis of large bowel cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Association of p53 mutations with short survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

What is the value of bcl-2 protein detection for histopathologists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

The p53 tumour suppressor gene and tumour prognosis: is there a relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002689900218

What does BCL-2 mean in solid tumours--friend or foe?

21 January 2018

1 reference

12 December 2020

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli

1 reference

12 December 2020

Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas

1 reference

12 December 2020

bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis

1 reference

12 December 2020

Bcl-2 initiates a new category of oncogenes: regulators of cell death

1 reference

12 December 2020

The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status

1 reference

12 December 2020

The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer.

1 reference

12 December 2020

p53 analysis in diagnostic pathology. Biologic implications and possible clinical applications

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002689900218

1 reference

1 July 2019

Dimensions Publication ID

0 references

1 reference

1 July 2019